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Abstract: A lanthanide-binding tag site-specifically attached to a 
protein presents a tool to probe the protein by multiple spectroscopic 
techniques, including nuclear magnetic resonance (NMR), electron 
paramagnetic resonance (EPR) and time-resolved luminescence 
spectroscopy experiments. Here we present a new stable chiral Ln(III) 
tag, referred to as C12, for spontaneous and quantitative reaction with 
a cysteine residue generating a stable thioether bond. The synthetic 
protocol of the tag is relatively straightforward and the tag is stable for 
storage and shipping. It displays greatly enhanced reactivity towards 
selenocysteine, opening a route towards selective tagging of 
selenocysteine in proteins containing cysteine residues. Loaded with 
Tb(III) or Tm(III) ions, the C12 tag readily generates pseudocontact 
shifts (PCS) in protein NMR spectra. It produces a relatively rigid 
tether between lanthanide and protein, which is beneficial for 
interpretation of the PCSs by single magnetic susceptibility anisotropy 
tensors, and it is suitable for measuring distance distributions in 
double electron–electron resonance (DEER) experiments. Upon 
reaction with cysteine or other thiol compounds, the Tb(III) complex 
exhibits a 100-fold enhancement in luminescence quantum yield, 
affording a highly sensitive turn-on luminescence probe for time-
resolved FRET assays and enzyme reaction monitoring.  
Introduction 
Site-specific labelling of proteins with lanthanide complexes offers 
a powerful tool for a range of spectroscopic techniques, including 
nuclear magnetic resonance (NMR), electron paramagnetic 
resonance (EPR) and luminescence spectroscopy. Paramagnetic 
lanthanide ions produce large effects in protein NMR spectra that 
present long-range structural restraints. Thus, paramagnetic 
relaxation enhancement (PRE) effects are observed for protons 
over 20 Å from a gadolinium(III) ion,1 pseudocontact shifts (PCS) 
are observable for nuclear spins over 40 Å from the paramagnetic 
centre2 and residual dipolar couplings (RDC) are observed 
throughout the entire molecule due to molecular alignment in the 
magnetic field conferred by a bound paramagnetic lanthanide ion 
(with the exception of Gd(III)).3 
 PCSs are of particular interest, as they are manifested in 
easy-to-measure changes in chemical shifts, which encode the 
position of the nuclear spin relative to the coordinate system 
defined by the magnetic susceptibility anisotropy () tensor 
associated with the paramagnetic centre. The PCS, PCS, of a 
nuclear spin is given by 
 
PCS = 1/(12r3)[ax(3 cos2 – 1) + 3/2 rh sin2 cos 2]        (1) 
 
where PCS is measured as the difference in chemical shift 
measured in the presence and absence of the paramagnetic 
metal ion, ax and rh are the axial and rhombic components of 
the  tensor, and r,  and  are the polar coordinates of the 
nuclear spin relative to the principal axes of the tensor. PCSs thus 
encode accurate long-range structural information that can be 
used for analysing protein conformations in solution and 
determining the structures of protein–protein and protein–ligand 
complexes.4–11 PCSs can even be used as the sole experimental 
restraints for protein fold determination.12–14 
 Among the paramagnetic lanthanide(III) ions, terbium(III) 
and thulium(III) stand out for featuring large  tensors and 
generating PCSs that tend to shift the NMR signals in opposite 
directions, assisting their assignment relative to the 
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corresponding diamagnetic reference, which can be prepared 
with a metal of similar ionic radius such as yttrium(III). (Yttrium is 
not a lanthanide but together with the lanthanides can be referred 
to as lanthanoid.) These three lanthanoid ions have thus been 
used extensively to assess the performance of lanthanide tags for 
PCS measurements in protein NMR.5,7,15 Stable lanthanoid tags 
enable PCS measurements in living cells and these data can be 
sufficient for 3D structure determinations of the tagged 
proteins.16,17 
 Gd(III) is the metal ion with the largest paramagnetic 
moment, which can be exploited not only for PRE measurements 
in protein structural biology but, even more prominently, in 
contrast agents for magnetic resonance imaging.18–20 Owing to 
slow electronic relaxation, Gd(III) ions have also gained an 
important role in EPR investigations, as double electron–electron 
resonance (DEER) experiments deliver precise distances 
between two Gd(III) ions ranging between about 2.5 and 8 nm.21–
24 Such measurements deliver unique data for probing the 
conformation of proteins following the attachment of Gd(III) tags 
at two sites.25,26 Unlike traditional nitroxide radicals, the EPR 
signal of Gd(III) tags is free of orientation selection effects at high 
(W-band) EPR frequencies, enabling sensitive DEER 
measurements, which can be analysed in a straightforward 
manner.27 Furthermore, Gd(III) tags are insensitive to chemical 
reduction under physiological conditions, which is important for in-
cell DEER measurements.28,29    
Distance information on the nanometre scale can also be 
obtained from Förster resonance energy transfer (FRET) 
experiments based on the luminescence of Tb(III) or Eu(III) ions. 
With suitable antennas for efficient photo-excitation, the 
luminescence is extremely sensitive and, besides serving 
applications in structural biology, these lanthanide ions offer 
outstanding probes in bioassays and for live cell-imaging.30-36 In 
particular, luminescent lanthanide tags are integral to commercial 
time-resolved Förster resonance energy transfer (TR-FRET) 
assays to study dynamic processes such as protein conformation, 
protein–protein interactions and receptor-ligand binding 
interactions.37–40 Ln(III) complexes of europium and terbium offer 
advantages over organic fluorophores for FRET-based assays, 
including up to millisecond excited state lifetimes, which enables 
background autofluorescence to be completely removed through 
time-resolved measurements, enhancing sensitivity.41,42 In 
addition, they possess narrow emission bands which enables 
selective observation of lanthanide emission, and large pseudo-
Stokes shifts, which minimises self-absorption processes.43,44  
 All these applications of lanthanoid ions demand stable 
attachments to the targeted biological macromolecule, which 
must be achieved by linking a suitable lanthanide chelating 
complex to the molecule, as proteins with natural high-affinity 
binding sites for lanthanoids are rare.45 Different approaches for 
tagging of proteins have been developed over the past two 
decades, most of which focus on attachment to single cysteine 
residues, as thiols are chemically more reactive than any other 
chemical group of the 20 canonical amino acids.5,46 Useful tags 
for single cysteine residues need to fulfil a number of criteria. (i) 
The tether connecting the lanthanide ion with the sulfur of the 
cysteine should be rigid, with the smallest possible number of 
rotatable bonds, as precise structural information can be obtained 
only if the lanthanide ion does not move relative to the protein.47 
At the same time, the tag must not affect the protein structure. (ii) 
The tagged protein should be chemically stable. Lanthanide tags 
producing thioether bonds are superior to lanthanide tags 
attached via disulfide bonds, which are sensitive towards 
reducing agents. Furthermore, a disulfide bond adds more 
flexibility to the tether than a thioether group. (iii) The lanthanide 
complex should be convenient to use to minimize protein 
handling. Most users prefer tags already containing the 
lanthanide ion over tagging approaches that require titration with 
lanthanides after installation of the tag, as achieving accurate 
titration ratios can be difficult. Furthermore, tags containing 
cysteine-reactive moieties are preferred over tags that require 
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prior chemical activation of the cysteine residue in the protein. (iv) 
The lanthanide complex of the tag needs to be kinetically and 
thermodynamically stable in order not to dissociate in aqueous or 
biological media. (v) For measurements of PCSs by NMR 
spectroscopy, the lanthanide complex must form a single 
stereoisomer to prevent peak doubling as a consequence of 
diastereomer formation in the chiral environment of the target 
protein.48–50 (vi) Synthesis of the lanthanide tag should be 
straightforward and affordable. Among the many tags published 
to date, the P4T-DOTA and Ln-M7-Nitro tags recently published 
by Häussinger and co-workers51,52 (Figure 1) fulfil these criteria, 
except that their synthesis is challenging. 
Here we present a new chiral lanthanide binding tag, C12, 
which is based on a stable cyclen complex, reacts rapidly with 
cysteine thiols in quantitative yield, produces a thioether bond and 
a rigid aromatic tether, and is enantiomerically pure and easier to 
synthesise than the P4T-DOTA or Ln-M7-Nitro tags. The tag 
combines the reactive para-nitropyridyl group of the previously 
reported Ln.L1 tag, where the nitro group acts as a leaving group 
in the reaction with cysteine,53 with the chiral phenylethylamide 
pendant arms of the C1 tag (Figure 1).54 We demonstrate the 
performance of this tag with different proteins for measuring PCSs 
in NMR experiments, Gd(III)–Gd(III) distances in double electron–
electron resonance (DEER) experiments, and luminescence in 
peptides and proteins labelled with the Tb(III) complex. We show 
that cysteine labelling of the Tb(III) complex of C12 elicits a 
dramatic 100-fold enhancement in Tb(III) luminescence from a 
dark background. The Tb(III) complex is resistant to oxygen-
mediated quenching and is suitable for use in homogenous time-
resolved luminescence assays, demonstrated by a FRET 
experiment with a labelled Aurora A protein kinase. Finally, we 
demonstrate fast and complete reaction with selenocysteine, 
which raises the prospect of site-selective tagging in the presence 
of cysteine residues. 
Results 
Lanthanide tag synthesis 
 
The synthesis of ligand C12 from 1,4,7,10 tetraazacyclododecane 
(cyclen) is described in Scheme 1. Briefly, the chiral 
bromocetamide arm 3 was prepared by reacting (S)-1-
phenylethanamine and bromoacetyl bromide, followed by N-
alkylation onto cyclen to give the macrocyclic compound 4. Next, 
N-alkylation of 2-methyl(sulfonyloxymethyl)-4-nitropyridine 2 onto 
the remaining secondary amine of compound 4 gave the ligand 
C12. Column chromatography was required after each alkylation 
step to remove impurities; however, the synthesis avoided the 
need for protecting groups and afforded ligand C12 in good 
overall yield. Lanthanoid complexes of C12 were readily prepared 
by the addition of one equivalent of the metal chloride salts, LnCl3 







To establish the fundamental chemical and photophysical 
properties of C12, its performance in luminescence applications 
was explored first. Photophysical data for the Tb(III) and Eu(III) 
complexes of C12 and the previously reported DO3A ligand L1,45 
together with their cysteine-tagged derivatives, are provided in 
Table 1. The Tb(III) and Eu(III) complexes of C12 have similar 
absorption spectra (Figure 2), characterized by a broad band 
centred at approximately 300 nm. Upon excitation of the 
nitropyridine moiety at 300 nm, the Tb(III) complex of C12 
displays weak emission with four characteristic bands in the green 
region (475 – 630 nm) of the visible spectrum (Figure 2a). The 
Eu(III) complex of C12 emits red light weakly upon excitation at 
300 nm, displaying characteristic emission bands in the range 550 
– 720 nm (Figure 2b). The quantum yields of the Ln-centred 
luminescence of C12 were determined by indirect excitation via 
the nitropyridine antenna to be in the range 0.1 – 0.2%. The 
emission lifetimes for Tb.C12 were 1.47 ms in H2O and 2.50 ms 
in D2O and corresponding values for the Eu(III) analogue were 
0.56 and 2.04 ms. In each case, the change in lifetime in 
deuterated solvent is consistent with one inner sphere water 
molecule (q = 1) for each Ln complex.55 
 
Scheme 1. Synthetic scheme for the lanthanide(III) tag Ln.C12 
Cysteine tagging reactions 
 
The ability of Tb.C12 to react with cysteine and other biological 
thiols was evaluated in water at pH 7.0. Incubation of Tb.C12 (250 
μM) with 4 mM cysteine (Cys), homocysteine (hCys) and 
glutathione (GSH) at 37 °C for 16 hours resulted in quantitative 
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Table 1. Photophysical data for the Tb(III) and Eu(III) complexes of C12 and 












Tb.C12 300 1200 0.23 1.47 2.50 1.1 
Tb.C12-Cys 278 15,500 20 1.48 2.40 1.0 
Eu.C12 297 1580 0.03 0.56 2.04 1.0 
Eu.C12-Cys 277 11,040 0.90 0.57 2.08 1.0 
a Values of hydration state q (±20%) were derived using literature methods.55 
Quantum yields were measured using quinine sulfate in 0.05 M H2SO4 as a 
standard (Φem= 52%).56 Errors in quantum yields and lifetimes are ±15%. 
 
Figure 2. Absorption and emission spectra for a) Tb.C12 and its cysteine 
derivative, and b) Eu.C12 and its cysteine derivative, measured in aqueous 
buffer (10 mM HEPES, pH 7.0). To emphasise the wavelength shift upon 
reaction with cysteine, the vertical axes of the absorption spectra for the 
cysteine derivatives of Tb.C12 and Eu.C12 were scaled down by a factor of 13 
and 7, respectively. To confirm that the emission intensity increase was due to 
the successful reaction of Tb.C12, rather than being associated with a non-
covalent binding interaction involving displacement of coordinated water, the 
cysteine derivative was purified by preparative reverse-phase HPLC. 
Upon ligation of cysteine, the Tb(III) complex of C12 exhibits 
a remarkable 100-fold enhancement in Tb(III)-centred 
luminescence (475 – 630 nm; Figure 2a). The Tb(III) emission is 
effectively ‘switched on’ upon ligation with cysteine. Similar 
enhancements in emission intensity were observed upon reaction 
with homocysteine and glutathione (Figure S2). The absorption 
spectrum of the purified complex, Tb.C12-Cys, showed a blue-
shifted band centred at 280 nm (Figure 2a), different from the 
untagged complex Tb.C12 (lmax = 300 nm). Notably, the extinction 
coefficient of Tb.C12-Cys was measured to be 15,500 M-1 cm-1, 
approximately 13-fold higher than the untagged complex. The 
overall quantum yield of the Tb(III) complex increased from 0.2 to 
20% following ligation with cysteine. The emission lifetimes for 
Tb.C12-Cys in H2O and D2O were very similar to those obtained 
for the unreacted complex Tb.C12 (Table 1), indicating one 
coordinated water molecule (q = 1) and confirming that the 
observed increase in Tb(III) luminescence was not associated 
with displacement of a water molecule by cysteine. 
 The substantial increase in both the quantum yield and the 
extinction coefficient upon ligation of Tb.C12 with cysteine means 
that the overall brightness of the Tb(III) complex, defined as the 
product of  and , increases approximately 1200-fold. In 
comparison, the Eu(III) complex of C12 exhibits a smaller 30-fold 
enhancement in Eu(III) luminescence upon reaction with cysteine 
(Figure 2b and Table 1) and the overall quantum yield increases 
only to about 1%. The ability of Tb.C12 to switch on its emission 
from a dark background confers significant advantages over other 
Ln(III)-based protein tags that display constant luminescence in 
their free form, including obviating the need for a washing step to 
remove the unreacted tag, and providing a luminescence method 
to report the extent of cysteine tagging under physiological 
conditions. 
 
Figure 3. Reaction yields with cysteine. a) Incubation of Tb.C12 (250 μM) with 
different equivalents of cysteine in water at pH 7.0 and different temperatures 
for 16 hours. Reaction completion monitored by ESI mass spectrometry (% 
cysteine-tagged MS peak). b) Total terbium emission intensity (λexc = 280 nm) 
after 24 hours incubation of Tb.C12 (250 μM) with various amino acids (4 mM) 
(black), and after further 24 hours incubation with cysteine (4 mM) (green). 
Incubations run in water at pH 7.0 and 37 °C. Emission spectra (λexc = 280 nm) 
recorded after 10-fold dilution into 10 mM HEPES, pH 7.0.  
The optimum number of equivalents of cysteine required to 
achieve near-quantitative ligation of Tb.C12 and Eu.C12 after 16 
hours was determined using ESI mass spectrometry, which 
revealed that four equivalents of cysteine were sufficient to 
achieve greater than 95% conversion at 37 °C after 16 hours 
(Figures 3a and S3–S5). Real-time monitoring of the reaction 
between Tb.C12 and cysteine at 37 °C was achieved using UV-
Vis and emission spectroscopy, which revealed complete reaction 
after 3 hours (Figure S6). 
 Next, the chemoselectivity of the tagging reaction was 
examined by incubation of Tb.C12 with a range of amino acids (4 
mM) containing nucleophilic functional groups in water at pH 7 
and 37 °C. After 24 hour incubation, no enhancement in Tb(III) 
emission intensity was observed with Lys, His, Arg, Ser, Tyr, Asp, 
Met, Asn or a combination of all of these amino acids, consistent 
with no reaction occurring (Figure 3b). This was verified by mass 
spectrometry (Figures S7 and S8), which showed only the signal 
for unreacted Tb.C12. The subsequent addition of 4 mM cysteine 
resulted in a substantial increase in Tb(III) emission intensity 
corresponding to formation of the cysteine complex (confirmed by 
mass spectrometry, Figures S7 and S8), demonstrating excellent 
selectivity for cysteine over all other nucleophilic amino acid 
residues.  
 Finally, dilution studies conducted with Tb.C12-Cys 
revealed that nanomolar concentrations of the Tb(III) tag can be 
readily detected using standard instrumentation (Figure S9). 
Further, the Tb.C12-Cys complex is completely insensitive to 
oxygen-mediated quenching (Figure S10). 
 Tb.C12 was shown to react rapidly and cleanly with the 
reduced form of GSH but not with the oxidized form (GSSG), 
which lacks the nucleophilic moiety (similar reactivity of Tb.C12 
was observed with cysteine over cystine, Figure S11). 
 




Figure 4. Monitoring glutathione reductase activity using Tb.C12. (a and b) Time-resolved emission intensity over time following addition of Tb.C12 (25 μM final 
concentration) to different concentrations of glutathione in 50 mM Tris-HCl, pH 7.4. (c and d) Time-resolved emission intensity (λexc = 292 – 366 nm, λem = 510 – 
500 nm, integration time = 60 – 400 μs) recorded 30 seconds after addition of Tb.C12 (25 μM final concentration) to different concentrations of GSH in 50 mM Tris-
HCl, pH 7.4. (e) Time-resolved emission intensity (corrected to allow for dilution and background reaction) against initial concentration of oxidised glutathione after 
adding Tb.C12 (25 μM final concentration) to a glutathione reductase reaction mixture containing NADPH (1 mM), glutathione reductase (0.01 U mL-1) and variable 
concentrations of oxidised glutathione (GSSG) in 50 mM Tris-HCl at pH 7.4 following a 30-minute incubation. Data fitted to the Michaelis-Menten equation.
We reasoned that the selective enhancement in Tb(III) emission 
intensity upon reaction with GSH could be utilized for monitoring 
the enzymatic conversion of GSSG to GSH. An attractive feature 
of Tb.C12 for this purpose is its long luminescence lifetime (1.47 
ms in H2O, Table 1), which permits time-resolved analysis of the 
GSH/GSSG ratio, wherein the introduction of a short delay (60 
ms) between the excitation and emission measurement enables 
complete removal of any short-lived autofluorescence from 
biomolecules in the sample, enhancing signal-to-noise. 
Additionally, any light scattering in the instrument is also avoided 
because the light source is off during acquisition of the emitted 
light. The first Tb(III) complex to be reported for monitoring 
glutathione reductase activity57 operates via Michael addition of 
GSH to a pendant maleimide arm, forming a thiol-maleimide 
conjugate with enhanced Tb(III) luminescence. However, 
maleimide–thiol conjugates are known to be susceptible to thiol 
exchange and ring opening reactions, which can compromise 
their longer-term stability.58,59  
 Tb.C12 was added to different concentrations of GSH and 
the time-resolved emission intensity recorded as a function of 
time. The increase in time-resolved luminescence was immediate 
(Figure 4a and b) and linearly dependent on GSH concentration 
even at low µM concentrations and for very short incubation 
(Figure 4c and d). After a 5-minute incubation period, the emission 
intensity increased about 3-fold. Again, the luminescence of the 
Tb(III) complex increased linearly with GSH concentration (Figure 
S12).  
To demonstrate the ability of Tb.C12 to monitor the 
reduction of GSSG to GSH, a series of enzyme reactions were 
carried out using glutathione reductase in the presence of the 
reducing agent NADPH and different concentrations of oxidised 
glutathione. After a 30-minute incubation period, Tb.C12 (25 µM) 
was added to the reaction mixture and the time-resolved emission 
intensity was recorded. Figure 4e shows a plot of the time-
resolved emission intensity as a function of initial GSSG 
concentration (corrected to account for the background of an 
enzyme-free reaction). As expected, increasing the GSSG 
concentration increased the emission intensity, consistent with an 
increased rate of reaction. The data were fitted to the Michaelis-
Menten equation to give a Michaelis-Menten constant, Km, of 1.14 
mM for GSSG. Thus, the rapid and selective reaction of Tb.C12 
with GSH over GSSG enables the enzymatic reduction of 
glutathione to be monitored in a convenient, luminescence-based 
increase-in-signal format.  
 
Protein ligation reactions for NMR analysis 
 
To explore the performance of C12 in NMR experiments, we 
prepared samples of the uniformly 15N-labelled ubiquitin mutant 
S57C and reacted with the Tb.C12, Tm.C12 or Y.C12 tags. 
Quantitative ligation yields were obtained in reactions conducted 
overnight at room temperature in 20 mM HEPES buffer, pH 7, as 
indicated by mass spectrometry (Figure S13). Ligation reactions 
with the proteins IMP-1 N172C, ERp29 S114C and ERp29 G147C 
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similarly resulted in fully tagged protein (Figures S14 and S15). 
All reactions were performed with 50 M solutions of protein at a 
tag:protein molar ratio of 5:1.  
 
Observation of PCSs and  tensors 
 
NMR experiments of the ubiquitin mutant S57C ligated with the 
Y.C12 tag displayed chemical shifts closely similar to the wild-type 
protein, indicating little if any structural perturbation introduced by 
the tag. The Tb.C12 or Tm.C12 tags produced significant PCSs 
(Figure 5a and Table S1). Observation of single peaks for each 
backbone amide confirmed that the presence of chiral 
phenylethylamide pendants resulted in a single diastereomer with 
the protein, which is a prerequisite for avoiding increased 
complexity of the NMR spectrum, thus enabling straightforward 
PCS measurements. As the C12 tag generates fewer rotatable 
bonds between lanthanide and protein backbone than the C154 or 
C260 tags, the C12 tag is expected to hold the metal ion more 
rigidly, thus resulting in less averaging between PCSs of different 
sign. Indeed, the PCSs measured with the C12 tag tended to be 
larger than those reported previously with the Tb.C1 tag (Figure 
S16)61 and the quality factor associated with the -tensor fit was 
significantly better (Table 2). 
 
 
 Figure 5. PCSs observed in ubiquitin S57C with C12 tag. (a) Superimposition of 15N-HSQC spectra. The C12 tag was loaded with Y(III) (black), Tb(III) (red) or 
Tm(III) ions (blue). The PCSs of selected amide protons are highlighted by lines connecting the corresponding cross-peaks of the protein with paramagnetic and 
diamagnetic tags. (b) Correlation plot of back-calculated versus experimental PCSs for backbone amide protons of ubiquitin S57C with the Tb.C12 (red) or Tm.C12 
tag (blue). (c) PCS isosurfaces representing the Δ tensor obtained with the Tb.C12 tag (left panel) or Tm.C12 tag (right panel) tag. The isosurfaces correspond to 
PCSs of +1 ppm (blue) and -1 ppm (red) and are plotted on the first conformer of the protein coordinates 2KOX.63 The backbone of the protein is drawn in a ribbon 
representation and the metal position is shown as a sphere. The -tensor fit positioned the paramagnetic centre about 6.3 Å from the Cα atom of residue 57, as 
anticipated from the covalent structure of the tag. 
Table 2. Δ-tensor parameters of ubiquitin S57C tagged with Tb.C12, Tm.C12 or Tb.C1a  
Tag Δaxb (10-32 m3) Δrhb (10-32 m3) x (Å) y (Å) z (Å) α (o) β (o) γ (o) Qc 
Tb.C12 -13.5(1) -8.0(1) 13.810 11.561 -3.533 65 56 87 0.01 
Tm.C12 11.1(2) 3.2(2) 13.810 11.561 -3.533 56 60 67 0.06 
Tb.C1d -9.06(3) -2.5(1) 17.220 8.370 -4.000 12 105 151 0.06 




a The Δ-tensor fits used PCSs measured with Tb(III) and Tm(III), using Y(III) as the diamagnetic reference and the NMR ensemble structure of  ubiquitin (PDB ID: 
2KOX).63 Fits with the Tb.C12 and Tm.C12 tags were to a common set of x, y and z coordinates of the metal position. Euler angles ,  and  are reported in 
degrees relative to the structure 2KOX. b Uncertainties (in brackets) were determined from fits obtained by randomly omitting 10% of the PCS data. c The quality 
factor was calculated as the root-mean-square deviation between experimental and back-calculated PCSs divided by the root-mean-square of the experimental 
PCSs. d Parameters reproduced from Pearce et al. (2017).61 
 
Figure 6. PCSs of the metallo--lactamase mutant IMP-1 N172C with the C12 tag. (a) Superimposition of 15N-HSQC spectra of IMP-1 N172C tagged with the C12 
tag loaded with Y(III) (black), Tb(III) (red) or Tm(III) ions (blue). The PCSs of selected amide protons are identified by lines connecting the corresponding cross-
peaks. (b) Correlation plot of back-calculated versus experimental PCSs for amide protons of IMP-1 N172C tagged with the Tb.C12 (red) or Tm.C12 tag (blue). (c) 
PCS isosurfaces representing the Δ tensors obtained with the Tb.C12 tag (left panel) or Tm.C12 tag (right panel) attached at position 172. The isosurfaces 
correspond to PCSs of +1 ppm (blue) and -1 ppm (red) and are plotted on the crystal structure 4UAM.64 The distance of the paramagnetic centre from the Cα atom 
of the tag attachment site is indicated by a dotted line. (d) Same as (c), but for the protein with Tb.C2 (left panel) and Tm.C2 tag (right panel). 
Table 3. Δ-tensor parameters of IMP-1 N172C tagged with C2 and C12 tags loaded with Tb(III) or Tm(III) ionsa 
Tag Δaxb (10-32 m3) Δrhb (10-32 m3) x (Å) y (Å) z (Å) α (o) β (o) γ (o) Qc 
Tb.C12 13.5(2) 6.4(2) 43.966 85.262 25.852 61 52 112 0.11 
Tm.C12 -10.5(2) -5.1(3) 43.966 86.252 25.852 57 54 106 0.12 
Tb.C2 -18.2(3) -4.7(2) 40.869 77.901 25.202 22 29 172 0.33 
Tm.C2 13.9(2) 3.6(3) 40.869 77.901 25.202 20 31 172 0.35 
a The Δ-tensor fits used PCSs measured with Tb(III) and Tm(III), using Y(III) as the diamagnetic reference. The metal coordinates and tensor parameters for the 
IMP1 mutant are reported relative to the crystal structure of IMP-1 (PDB ID: 4UAM).64 Uncertainties (in brackets) were determined from fits obtained by randomly 
omitting 10% of the PCS data and the quality factor was calculated as described in footnote b of Table 2. 




To confirm these results, we also tagged the N172C mutant 
of the Pseudomonas aeruginosa metallo--lactamase IMP-1 with 
C12 and C2 tags. The wild-type protein already contains a 
cysteine residue, but this residue coordinates the two zinc ions in 
the active site62 and proved to be unreactive towards the tags. As 
in the case of ubiquitin, conservation of the NMR chemical shifts 
following ligation with Y.C12 or Y.C2 indicated maintenance of 
structural integrity. Following ligation with tags loaded with Y(III), 
Tm(III) or Tb(III) ions, PCSs were observed both with the C12 and 
C2 tags (Tables S2 and S3). In this case, the C12 tag produced 
smaller  tensors than the C2 tag (Figures 6 and S17), but the 
Q factors of the -tensor fits were consistently better (Table 3). 
In the case of IMP-1, the  tensor fits identified lanthanoid ion 
positions that were slightly further from the protein backbone for 
the C12 than the C2 tag (Figure 6c and d). It is unclear whether 
this indicates de-coordination of the pyridine moiety in the C12 tag 
(despite limited lanthanide hydration indicated by q = 1 for the 
derivative with cysteine; see Table 1), or is an artifact of fitting a 
single  tensor to PCS data generated by a mobile tag, which 
places the metal ion at variable positions relative to the protein.47 
 
EPR characterisation of the Gd.C12 tag 
 
To evaluate the performance of Gd.C12 for DEER applications 
we turned to ERp29. It is a homodimeric protein and its mutants 
S114C and G147C have been used previously to assess the 
performance of different gadolinium tags for distance 
measurements.65–67 Figure 7 compares the EPR line shape of the 
Gd.C12 tag ligated to ERp29 S114C and ERp29 G147C with that 
of the free tag. The line shape of the central ms |-1/2>->|1/2> 
transition is similarly narrow as that of the structurally related C1 
and C9 tags66 and undergoes minimal change upon attachment 
of the tag to the protein, except for about two-fold narrowing of the 
central transition. T1 relaxation (120 s, 10 K) as determined from 
three-pulse inversion recovery did not change significantly 
between the unbound and bound tag (Figure S18, Table S4). 
Phase memory times TM (8–10 s) as determined from spin-echo 
decay experiments were also similar (~15% longer, Table S6), 
provided the protein was incubated in D2O over 24 hours (Figure 
S19). As the protein samples were not perdeuterated, the 
sensitivity of TM to hydrogen exchange must be attributed to 
amide and hydroxyl groups, most likely the amides of the pendant 


















Figure 7. Central transition of echo-detected EPR spectra of the Gd.C12 tag, 
free and bound to cysteine mutants of ERp29 recorded at 94 GHz (scaled to 
frequency). The full width at half maximum (fwhm) of the central sharp |-1/2> -> 
|+1/2> transition are annotated on each spectrum. The pump and probe pulse 
positions applied for the DEER experiments of ERp29 S114C and ERp29 
G147C are indicated. The inserts show the full spectra. Lineshape simulations 
are shown in Figure S20. 
DEER experiments 
 
DEER measurements performed with the mutants S114C and 
G147C of ERp29 ligated with the Gd.C12 tag are shown in Figure 
8. A modulation depth  of about 6–8% was obtained, which is 
very good for DEER with Gd(III).68 For the mutant S114C and 
G147C, narrow distance distributions centred at 5.7 and 5.6 nm 
respectively were observed, in close agreement with modelling by 
tag rotamer libraries generated with the program PyParaTools69 
(Figure S23). These distances are somewhat shorter than 
obtained with the C1 tag, which were 6.1 and 5.7 nm, 
respectively.65 The shorter distance obtained with the C12 tag can 
be attributed to the shorter linker length to the cysteine residues, 
which was also reflected in the modelled distance distributions 
(Figures S22 and S23). Despite a more rigid linker, the 
experimentally determined distribution widths obtained with C12 
were similar to those obtained with the C1 tag. 
 The performance of C12 is also comparable with the C7 and 
C8 tags, which display distances closer to 6 nm.67 All three tags 
have the same number of bonds in the linker between the cyclen 
ring and cysteine residue. Comparing the distribution widths with 
those obtained with the C7 and C8 tags is more difficult, because 
these tags yield remarkably narrow distance distributions for 
ERp29 S114C but, for unknown reasons, unexpectedly broad 
distributions for ERp29 G147C.67 As this is not observed for C12, 
this difference must be an artefact, which we speculate the C12 
tag is less susceptible to. 




Figure 8. DEER distance measurement of ERp29 S114C (left panel) and 
ERp29 G147C (right panel) tagged with Gd.C12. (a) Form factor after 
background subtraction. The vertical axis plots the normalized echo intensity, 
the red line corresponds to the fitted trace. (b) Distance distribution calculated 
by DeerAnalysis2018.70 The red lines indicate the maxima of the modelled 
distance distributions. The full DEER data are shown in Figure S21. 
 
Time-resolved FRET using Tb(III)-labelled Aurora A kinase 
 
Distance information on the nanometre scale can also be 
obtained from FRET experiments utilising luminescent Tb(III) or 
Eu(III) donors. The selective reaction of Tb.C12 with cysteine-
containing biomolecules, coupled with its bright and long-lived 
luminescence signal upon labelling, make the Tb(III) complex an 
ideal candidate for use in homogenous time-resolved FRET 
assays.39,71,72 Due to the spectral overlap of the emission bands 
of Tb.C12 and the absorption spectrum of AlexaFluor 633 
(AF633; λexc 633 nm, λem 650 nm), these two molecules were used 
as a FRET donor and acceptor, respectively. The suitability of 
thiol-tagged Tb.C12 and AF633 as a FRET donor/acceptor pair 
was established in experiments conducted with GSH-tagged 
Tb.C12 donor and freely diffusible AF633 acceptor, which 
indicated a rate constant for energy transfer of 1.5 x 109 M-1 s-1 
(Figure S24). 
 To demonstrate FRET experiments in a protein, we used a 
construct of the protein kinase Aurora A engineered to contain 
exactly two surface cysteine residues 
(D274N/S278C/C290A/H373C/C393A mutant). Aurora A 
regulates entry into mitosis and other processes integral to cell 
proliferation and is a target of several cancer drug discovery 
programmes.73–75 Incubating the protein with Tb.C12 at 4 °C and 
pH 7.4 for 18 hours, the maximum enhancement in Tb(III) 
emission intensity was observed for a tag:protein molar ratio of 
4:1 (Figure S25).  
 FRET measurements of Aurora A were performed following 
stochastic labelling with the Tb.C12/AF633 pair, using 15 M 
solutions of Aurora A and 120 M solutions of Tb.C12, whilst 
varying the concentration of AF633 from 0 – 60 M. Background 
fluorescence from the sample was effectively eliminated by 
applying a time delay of 60 μs between excitation (λexc = 292 – 
366 nm) and detection (λem = 510 – 550 nm for Tb.C12 or 660 – 
670 nm for AF633). FRET was demonstrated by the presence of 
AF633 acceptor decreasing the Tb(III) emission intensity (Figure 
9a), time-resolved emission intensity of the AF633 acceptor, 
which increased in a concentration dependent manner (Figure 
9b), and a concomitant decrease in the Tb(III) emission lifetime 
(Figure 9c). These data are consistent with increasing FRET due 
to an increase in the number of protein molecules stochastically 
labelled with both donor and acceptor dyes. The labelling sites on 
Aurora A are expected to be separated by 19 – 31 Å (no single 
distance since one site is on a flexible loop) indicating that high 
FRET signals can be detected in this distance range. Control 
experiments involving the protein tagged only with the AF633 
acceptor confirmed that both the donor and acceptor must be 
present for FRET to be observed (Figure 9).  
We used our measured quantum yield and 
absorbance/emission spectra to calculate the critical distance (R0) 
for the Tb.C12-AF633 FRET pair.  We determined this to be 53 ± 
4 Å which is similar to that for many other commonly used FRET 
pairs. We cannot easily calculate the expected FRET efficiency 
for specific distances using this value of R0 since our standard 
calculation assumes free rotation of both dye molecules (i.e. 2 
=2/3) and our NMR measurements indicate that this is unlikely to 
be the case for Tb.C12. Nevertheless, our measurements of high 
FRET in the 19 – 31 Å range are consistent with our calculation 
which predicts FRET efficiency >78% for values of 2 for these 
distances in the physically meaningful range 0.1 ≤ 2 ≤ 4. Thus, 
we conclude that Tb.C12 is highly suitable for time-resolved 
FRET assay. 
Figure 9. Time-resolved emission intensity (λexc = 292 – 366 nm, integration time = 60 – 400 μs) of Tb(III) emission (λem = 510 – 550 nm) and AF633 emission (λem 
= 660 – 670 nm). The tagging reaction was performed by incubating 15 μM Aurora A with 120 mM Tb.C12 and different amounts of AF633 at 4 °C for 18 hours in 
50 mM Tris-HCl, 50 mM NaCl, 1.8% DMSO at pH 7.4. Control experiments involved Aurora with no Tb(III) complex (red) or only AF633 (orange). (a) Tb(III) emission 
after incubation of Aurora A with different equivalents of AF633 (relative to Aurora A). (b) Same as part a, but monitoring AF633  emission. Some background 
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emission observable without AF633 is expected from the emission spectrum of the Tb(III) tag (Figure 2a).   (c) Tb(III) emission lifetimes (λexc = 280 nm, λem = 545 
nm) of the samples in part b. 
Selectivity of the C12 tag for selenocysteine  
 
The broad utility of C12 for many different types of experiments 
prompted us to explore its potential for site-selective tagging of 
proteins containing selenocysteine residues. The selenol group of 
selenocysteine (Sec) is much more nucleophilic than the thiol 
group of cysteine and recently developed technology for genetic 
encoding of a photocaged selenocysteine residue, in principle, 
enables site-specific installation of a selenocysteine residue, 
although the protein yields obtainable are still too low for routine 
use.76 As solvent-exposed selenocysteine residues are highly 
prone to forming Se–Se bonds, free selenol groups can be 
maintained only in the presence of reducing agents,77 which are 
incompatible with tags that contain activated disulfide bonds. In 
the present work, we therefore tested the compatibility of the C12 
tag with reducing agents and its potential for ligation to 
selenocysteine. 
The mutant Q32Sec of the protein GB1 was prepared by 
cell-free protein synthesis with the exclusion of cysteine and 
provision of selenocystine to incorporate selenocysteine in 
response to the cysteine codon. Tagging reactions with Y.C12 
were conducted in parallel with GB1 Q32Sec and GB1 Q32C. The 
reaction with GB1 Q32Sec was complete within 10 minutes, 
whereas only a small fraction of GB1 Q32C had reacted even 
after 5 hours at room temperature (Figure 10). After the tagging 
reaction, GB1 Q32Sec displayed three additional mass peaks, 
two of which may be attributed to the reduction of the 
selenocysteine residue to serine (m/z = 8275.86 Da) and alanine 
(m/z = 8256.85 Da) caused by the presence of TCEP, which are 
not amenable to reaction with the C12 tag. The third minor peak 
(m/z = 8292.85 Da) may arise from a minor level of cysteine 
instead of selenocysteine incorporation. These results indicate 
that the correctly tagged protein was the main species and 
illustrate the potential of selenocysteine for site-specific tagging in 
the presence of free thiol groups. 
 Discussion 
Many lanthanide tags have been developed and compared for 
PCS and DEER measurements.5,7,24 Most of the tags are 
designed for attachment to single cysteine residues in the target 
proteins, either via a disulfide or a thioether bond. Thioether 
bonds are generally preferrable, as they produce a shorter tether 
between metal ion and protein, and disulfide bonds tend to be 
flexible and readily broken by chemical reduction. Attachment via 
thioethers has been obtained with tags containing 
phenylsulfonated pyridines,78–80 bromo- or iodoacetamides81–83 or 
(methylsulfonyl)thiazolo[5,4-b]pyridines,51,78 or by a thiol-ene 
reaction.84 Phenylsulfonated tags react only slowly with cysteine 
residues78 and require high solvent exposure of the thiol group. 
Halo-acetamides entail a relatively long and flexible tether with 
cysteine and tend to be unstable towards lyophilisation.81,82 
(Methylsulfonyl)thiazolo[5,4-b]pyridines, such as in the P4T-
DOTA tag (Figure 1), combine high reactivity towards thiol groups 
with high rigidity of the resulting tether between protein and metal 
ion, but the synthetic protocol of this group involves a number of 
steps of modest yield.51 The methylsulfonyl group on the activated 
pyridine ring of the Ln-M7-Nitro tag (Figure 1) reacts with 
cysteine thiols within minutes,78 which may make it difficult to 
selectively tag selenocysteine in the presence of cysteine. 
Figure 10. Mass spectra illustrating the much faster reaction of the Y.C12 tag 
with selenocysteine than cysteine. (a) and (b) Reaction with the mutant GB1 
Q32Sec after 5 and 10 minutes, respectively. The calculated masses of the 
untagged and tagged proteins are 8339.98 and 9172.32 Da, respectively. (c) 
and (d) Reaction with the uniformly 15N-labelled mutant GB1 Q32C after 10 
minutes and 5 hours, respectively. The masses calculated for 100% 15N-
enriched untagged and tagged proteins are 8388.38 and 9220.73 Da, 
respectively. 
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The 4-nitropyridyl group of the C12 tag combines good reactivity 
with a rigid resulting tether, which is shorter than that obtained 
with (methylsulfonyl)thiazolo[5,4-b]pyridines. An important 
advantage of the 4-nitropyridyl group as the tethering moiety is its 
ready synthetic accessibility allowing installation on the cyclen 
ring in just three steps (Scheme 1). In preliminary experiments, 
we observed that the C12 tag was significantly more reactive 
towards cysteine thiol groups than the related Ln.L1 tag (Figure 
1),53 suggesting that the electrophilicity of the pyridine ring is 
enhanced if the positive charge of the lanthanide ion is not 
compensated by negatively charged acetate pendants. The effect 
supports the notion that the metal ion is directly coordinated by 
the nitrogen of the pyridine ring as designed. Finally, the reactivity 
of the C12 tag is compatible with the presence of TCEP to 
maintain cysteine and selenocysteine in their reduced forms and 
it is sufficiently stable for shipping at room temperature. Despite 
its more modest reactivity compared with the Ln-M7-Nitro tag, we 
readily obtained 100% ligation yields with different proteins, 
without any evidence of reaction with amino acids other than 
cysteine. Notably, however, the large hydrophobic pendants of 
the C12 tag and its positive net charge carry the potential for 
undesired interactions with the protein. While this cannot be 
excluded, the present work found no evidence for such effects. 
As in the C1 and C2 tags,54,60 the chiral phenylethylamide 
groups on the cyclen ring of the C12 tag shift the equilibrium 
between different diastereomeric conformations of the lanthanide 
complex towards a single species, which is maintained in the 
adduct with a target protein. As expected for a shorter and more 
rigid tether between protein and metal ion, the present results 
confirmed our expectations that the C12 tag in general delivers 
larger PCSs and -tensor fits of better quality than the C1 and 
C2 tags. The Gd.C12 tag also proved to be applicable for the 
measurement of DEER distance distributions, which displayed 
comparable short distances and distribution widths. 
 An outstanding feature of the C12 tag is its capacity to form 
a stable selenoether bond with selenocysteine. The greater 
reaction rate of the C12 tag observed with selenocysteine 
compared with cysteine is underpinned by the greater 
nucleophilicity of a selenol versus thiol group near neutral pH. 
This sets the stage for site-selective tagging of a protein that 
contains a single selenocysteine residue, regardless of the 
presence or absence of cysteine residues. We anticipate that this 
will present an attractive approach once systems become 
available that incorporate caged selenocysteine residues with 
greater yield than hitherto achievable,76,85 as the specificity 
towards selenocysteine would eliminate the need to mutate native 
cysteine residues which is a major bottleneck for large proteins 
that contain several cysteine residues.  
 Finally, while double-arm tags attached to two neighbouring 
cysteine residues immobilise metal ions more easily,81,86–90 
suitable sites for double-cysteine mutations require careful 
selection and stable attachment of the tag is not guaranteed.91 
Strategies that immobilize the lanthanide ion by simultaneous 
coordination to two phosphoserine residues92 or chelating 
moieties installed on neighbouring cysteine residues93,94 are 
similarly restricted in the choice of attachment sites. By allowing 
attachment to a single amino acid residue, the C12 tag opens a 
much greater choice of suitable tagging sites. 
 Among the cyclen tags that react with cysteine by formation 
of a stable thioether bond,17,51,68,78,79,81,82 the most recent designs 
use a linker with an aromatic ring that is capable of coordinating 
the lanthanide ion. This design is attractive as it rigidifies the 
tether to the protein53 and in this way limits the averaging between 
positive and negative PCSs that occurs when the lanthanide 
complex reorientates relative to the protein. This design is also 
attractive for DEER measurements in order to obtain the 
narrowest possible distance distributions. Our present results 
indicate that the different widths in distance distribution obtained 
for the sites 114 and 157 in ERp29 mostly reflect the 
conformational space accessible to the tags, as both C1 and C12 
yield consistently narrower distribution widths for the site 114 than 
the site 157 and the latter is more solvent-exposed. Despite a 
shorter and more rigid tether in C12, however, the widths of the 
distance distributions were similar, contrary to our simulations 
which assumed stable coordination between the pyridine nitrogen 
atom and Gd(III) ion. In contrast, our NMR data suggested that 
the C12 tag restricts translational movements of the lanthanide 
ion relative to the protein better than the C1 tag, as manifested by 
better quality factors obtained in the -tensor fits of Tb.C12 on 
the cysteine mutants of ubiquitin and IMP-1 compared to those 
obtained with the Tb.C1 and Tb.C2 tags (Tables 2 and 3).47 
Notably, the Gd.C7 and Gd.C8 tags delivered much narrower 
distance distributions for the ERp29 mutant S114C, but 
unexpectedly broad distributions for the G147C mutant.67 A 
similar discrepancy between these two sites was obtained with 
the Gd.C9 tag (Figure 1), indicating that the widths of the distance 
distributions very much depend on the specific tag and its 
interactions with the protein environment.66 This may hold in 
particular for tags with very rigid linkers, as any chemical tag can 
potentially also affect the protein structure and rigid tags may be 
more problematic in this regard. In the case of the Gd.C12 tag, 
the distance distribution widths varied less between different sites 
than for the previously published Gd.C7 and Gd.C8 tags.67 In 
addition, each backbone amide displayed a single peak in the 
protein NMR spectra, indicating fast exchange between different 
tag conformations as far as they occur. More examples will need 
to be evaluated to confirm the consistency in the performance of 
the C12 tag. 
 On a technical note, the DEER measurements with Gd.C12 
delivered a maximal modulation depth of almost 8%, which is 
similar to the record modulation depth of 9% reported for the 
[Gd.sTPATCN]-spin label.68 For DEER measurements using 
nitroxide spin labels, it is well-known that the phase memory time 
can be greatly extended by perdeuteration of the protein.95,96 As 
deuteration of exchangeable hydrogens was sufficient to extend 
the phase memory time of the Gd.C12 tag, it may possibly be 
extended further by synthesizing the tag and/or protein in 
perdeuterated form. In past experiments of ERp29 S114C tagged 
with Gd.C1, however, perdeuteration did not extend the phase 
memory time very much.65 
 In our luminescence experiments, cysteine labelling of the 
Tb(III) complex of C12 elicited a remarkably large enhancement 
in both the extinction coefficient ( increases from 1,200 to 15,500 
M-1 cm-1) and emission quantum yield ( increases from 0.02 to 
20%). The ability to ‘switch on’ Tb(III) emission upon labelling is 
highly advantageous for time-resolved luminescence assays, as 
it avoids cumbersome washing/purification steps and permits 
dynamic imaging of biochemical processes in high-throughput 
format. Other protein-labelling methods which display fluorogenic 
behaviour, such as SNAP-tag technology97 require the 
attachment of the fluorophore to a quencher group, which is 
released when the tag reacts with the target biomolecule. In the 
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present work, we exemplified the performance of the Tb.C12 tag 
in straightforward microplate reader-based bioassays, monitoring 
the enzymatic reduction of glutathione and observing time-
resolved FRET within a model protein kinase, Aurora A. The 
quantum yield of the thiol-tagged Tb.C12 is approximately 10 
times larger than that of the europium(III) cryptate ( = 0.02)98 
used in several commercial homogeneous time-resolved FRET 
assays, indicating that a 10-fold increase in sensitivity is 
achievable with the Tb.C12 tag in such assays. The commercially 
available Lumi4-Tb tag, which exhibits unequalled brightness 
(15,800 M-1 cm-1 at 340 nm in water versus 3,100 M-1 cm-1 for 
Tb.C12-Cys at 280 nm), is not silent in its untagged form.33 
Conclusion 
In summary, the C12 tag combines many favourable features, 
including stable lanthanide binding in a complex forming a single 
conformation, a relatively short tether favouring high-quality -
tensor fits, high reactivity towards cysteine and selenocysteine, 
attachment to a single solvent-exposed thiol or selenol group, 
and, last but not least, relative ease of synthesis and convenience 
of use in the tagging reaction which, important for tagging of 
selenocysteine, can be conducted in the presence of reducing 
agents such as TCEP. The  tensors measured by NMR are of 
useful magnitude, the EPR properties of the Gd.C12 tag make it 
suitable for DEER distance measurements and the outstanding 
luminescent properties of the Tb.C12 tag open a host of attractive 
applications in structural biology, enzymology and, potentially, 
even live-cell imaging applications. We hope to improve these 
further by modification of the antenna of the Tb.C12 tag to 
increase its excitation wavelength towards the visible region. 
Overall, we anticipate that the broad applicability and 
convenience of the C12 tag will make it an exceptionally popular 
tool. 
Experimental Section 
The protocols for synthesis and characterisation of complexes 
Tb.C12, Eu.C12, Tm.C12, Gd.C12 and Y.C12 are provided in the 
ESI, as are the protocols for protein production, purification and 
tagging. The ESI also reports the general procedures for the 
reaction of Ln.C12 with low molecular weight thiols, glutathione 
reductase reactions and tagging of Aurora A with Tb.C12 and 
AlexaFluor 633. 
 
Extinction coefficients and quantum yields 
 
Extinction coefficients of Ln.C12 or Ln.C12-Cys (Ln = Tb or Eu) 
(1 mg mL-1) were determined in 10 mM HEPES pH 7.0. Quantum 
yields were measured using quinine sulfate in 0.05 M H2SO4 as a 
standard (Φem= 0.52, lex = 350 nm).56 The total emission intensity 
(450 – 720 nm) was determined for all compounds and compared 




Luminescence spectra were recorded on a Camlin Photonics 
luminescence spectrometer with FluoroSENS version 3.4.7.2024 
software. Emission spectra were obtained using a 40 µL Hellma 
Analytics quartz cuvette (Art no. 111-10-K-40). Excitation light 
was set at 280 nm (or 300 nm for untagged Ln(III) complexes), 
and emission read in the range 400 – 720 using an integration 
time of 0.5 seconds, increment of 1.0 nm and excitation slit of 0.2 
nm and emission slits of 0.5 nm. Plate reader data were obtained 
on a BMG Labtech CLARIOstar microplate reader in black 
Fisherbrand™ 384-well plates, using a total volume of 40 μL per 
well.  
 Emission lifetime measurements were performed on the 
same instrument. Measurements were taken of 1 mL of 0.1 
absorbance samples of Ln complexes in 10 mM HEPES, pH 7.0. 
Measurements were obtained by indirect excitation of the Ln ion 
via the pyridine antennae using a short pulse of light at λmax (300 
nm for untagged complexes, 280 nm for thiol-tagged complexes), 
followed by monitoring the integrated intensity of the light emitted 
at 546 nm (Tb complexes) or 615 nm (Eu complexes), with 500 
data points collected over a 10 millisecond time period. The decay 
curves were plotted in Origin Labs 2019 version 9.6.0.172, and 
fitted to the equation:  
 
I = A0 + A1 𝑒−𝑘𝑡   (1) 
 
where I is the intensity at time, t, following excitation, A0 is the 
intensity when decay has ceased, A1 is the pre-exponential factor 
and k is the rate constant for the depopulation of the excited state. 
 The hydration state, q, of the Eu(III) and Tb(III) complex of 
C12 was determined using the modified Horrocks equation:55 
 
q(Eu) = 1.2 (1/H2O – 1/D2O − 0.25 − 0.075n)  (2) 
 
q(Tb) = 5 (1/H2O − 1/D2O − 0.06)  (3) 
 
where H2O and D2O are the emission lifetime times in water and 
D2O, respectively, and n is the number of carbonyl-bound amide 
NH groups. 
 
Study of specificity for selenocysteine versus cysteine  
 
The tagging reactions of the proteins GB1 Q32Sec and GB1 
Q32C were carried out in parallel, using 50 μM GB1 mutant, 250 
μM Tb.C12 tag and 1 mM TCEP. Progress of the reaction was 
monitored by sampling 10 μL aliquots from the reaction mixture 
after 5, 10, 15, 30, 45 and 60 minutes, as well as after 5 hours. 
The reaction was quenched by the addition of 0.1 % TFA and 
snap freezing for storage. The final samples were analysed by 
intact protein mass spectrometry. 
 
Intact protein mass spectrometry 
 
Intact protein analysis was carried out on an Orbitrap Fusion 
Tribrid mass spectrometer (Thermo Fisher Scientific, USA) 
connected to a Thermo Fisher Scientific UltiMate 3000 HPLC 
system equipped with ZORBAX 300SB-C3, 3.5 μm, 4.6 × 50 mm 
HPLC column (Agilent Technologies, USA). Each HPLC run was 
performed with 500 μL/min linear gradient of solvent A (0.1 % (v/v) 
formic acid in water) and solvent B (0.1 % (v/v) formic acid in 
acetonitrile), ramping solvent B from 5% solvent B at the start to 
80 % after 12 min. Data were collected using an electrospray 
ionization (ESI) source in positive ion mode. Protein intact mass 
was determined by deconvolution using the Xtract function in the 
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Qual Browser software tool of the program Xcalibur 3.0.63 
(Thermo Fisher Scientific, USA). 
 
NMR measurements  
 
All NMR data were acquired at 35 °C on a Bruker 600 MHz 
Avance NMR spectrometer equipped with a TCI cryoprobe. The 
PCSs of amide protons were measured in 15N-HSQC spectra 
recorded with acquisition times of t1max = 90 ms and t2max = 122 ms. 
The PCSs were measured in ppm as the chemical shifts in the 





Δ-tensor parameters were determined using the program 
Paramagpy,99 using the PCSs of backbone amide protons and 
atomic coordinates from the Protein Data Bank (PDB ID 2KOX63 
for the structure of ubiquitin and 4UAM64 for the structure of IMP-
1). The quality of the fit was assessed by the Q factor, which was 
calculated as the ratio of the root-mean-square deviation between 
experimental and back-calculated PCSs and the root-mean-




All EPR measurements were performed at 10 K on a modified 
Bruker EPR spectrometer operating at W-band (94 GHz).100 The 
line shape of both the protein-bound and free Gd.C12 tag was 
measured by an electron spin-echo field-sweep /2 –  –  – echo,  
using  /2 = 40 ns,  = 80 ns and  = 500 ns. T1 relaxation was 
measured by the inversion recovery sequency  – t + dt – /2 –  
–  – echo. The integrated echo intensity was recorded as a 
function of time t incremented in intervals dt, using the same pulse 
lengths as above. T2 relaxation was measured by recording the 
decay of the integrated echo intensity with time, using the pulse 




The standard four-pulse DEER sequence (/2(obs) – t1 – (obs) 
– (t1 + dt) – (pump) – (t2 – dt) – (obs) – t2 – echo) was used with 
averaging over the initial time delay to remove nuclear modulation 
artefacts; each scan was acquired by averaging four different t1 
values from 400 – 562 ns. The DEER echo was observed at 93.94 
GHz with /2 and  pulses of 16 ns and 32 ns, respectively, and 
an ELDOR pulse of π = 16 ns at 120–130 MHz above the probe 
frequency. Other parameters used were a repetition rate of 255 
µs, dt = 20 ns and t2 = 7.6 µs. The field position for detection was 
set at the peak of the Gd(III) spectrum (Figure 7), applying the 
pump pulse at the centre of the Gd spectrum and the probe pulse 
on the edge of the ms |-1/2> -> |1/2> transition.  
The data were analysed using DeerAnalysis201870 and 
distance distributions were obtained using Tikhonov 
regularization. The regularization parameter was chosen by the 
L-curve criterion. Estimation of uncertainties in distance 
distributions due to background correction were obtained using 
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